Tutorials › Competing Risks and Multi-State Models › Defining Causes, Competing Events, and Censoring in Methods

Reporting Competing-Risk Analyses · Tutorial 686 of 699

Defining Causes, Competing Events, and Censoring in Methods

Build clear, auditable definitions that distinguish competing events from censoring and make follow-up and cause assignment reproducible.

Intermediate 10 min read

What You'll Learn

  • Specify an event of interest using operational eligibility, timing, and ascertainment rules.
  • Distinguish a competing event from censoring by whether an observed event precludes the target event under the defined endpoint.
  • Define the time origin, follow-up start and end, and censoring dates precisely.
  • Document adjudication, unknown causes, multiple causes, and tied event times.
  • Check whether the chosen event categories form a clear, mutually exclusive classification.

Why Definitions Belong in the Methods

A competing-risk analysis is only interpretable if readers can tell what counted as an event, which events were treated as competing, and when follow-up ended. Those decisions are not clerical details. For example, “cardiovascular event” could mean a first myocardial infarction, any hospitalization for a cardiovascular diagnosis, or cardiovascular death. Those definitions produce different observed event histories. A reproducible methods description lets another analyst classify the same records in the same way.

The aim here is to write the event and follow-up rules clearly, not to choose an estimand or report its estimate. The earlier material on choosing and naming the reported competing-risk estimand addresses that separate decision. Here, the practical task is to state exactly how the records were converted into event types and observed follow-up.

Definition: An event of interest is an outcome specified in advance by clinical or scientific criteria, including the population, qualifying event features, and time of occurrence. A competing event is a distinct event that occurs before the event of interest and, under the stated endpoint definition, makes that event of interest impossible to occur subsequently as the first event being studied. Censoring occurs when observation ends before a qualifying event is observed; it records incomplete event-time information, not a type of event.

For a simple first-event analysis, let \(T_i\) be subject \(i\)'s time from the stated time origin to the first qualifying event, and let \(C_i\) be the time from that origin to censoring. The observed time is \(Y_i=\min(T_i,C_i)\). If an event is observed, its cause label \(J_i\) identifies the event type; if follow-up is censored first, \(J_i=0\) denotes censoring. With \(K\) defined event types, an observed cause label is one of \(1,\ldots,K\). This notation is useful only when the event categories and the censoring rule are clearly specified.

A competing event is therefore not simply “an event other than the one of interest.” It must be an observed outcome that prevents the target first event from occurring later in the defined event process. Death before a nonfatal relapse is a common example: after death, a later relapse cannot occur. By contrast, an administrative end of observation does not establish that relapse will never occur; it is censoring. If events can recur, or one event does not preclude another, the study endpoint and event-history structure need to say so rather than forcing every outcome into a first-event classification.

Write the Classification Rules Before Applying Them

A useful methods description makes the classification reproducible by answering four questions: what qualified, when it counted, how its cause was assigned, and what happened when assignment was uncertain or more than one cause seemed applicable. Define the event in observable terms, such as a prespecified diagnostic criterion, a laboratory threshold, or a documented clinical event. State the data sources used to establish it and any adjudication process. A broad label without operational criteria leaves analysts to make unstated judgments.

For first-event categories, the recorded cause labels should ordinarily be mutually exclusive and collectively cover all observed qualifying first events. If one record meets criteria for two categories, a hierarchy, adjudication rule, or explicit “multiple/uncertain cause” category is needed. Do not silently assign the event to whichever category is most convenient. If a genuinely overlapping event process is scientifically important, a multi-state representation may be more appropriate than a forced single cause label.

Cause assignment can be based on a prespecified source, such as a blinded adjudication committee, a registry field, or a defined combination of clinical records. State how disagreements were resolved and how unclassifiable events were handled. “Unknown cause” is not automatically censoring: the event itself may be known to have occurred even when its cause is not. The analysis plan should distinguish missing cause information from absence of an event and explain whether such cases are retained as a separate category, excluded from cause-specific classification, or addressed through a sensitivity analysis.

Worked Example: Defining a First Event After Transplant

Suppose a hypothetical study follows 120 transplant recipients for graft failure. Investigators want a first-event classification with graft failure as the event of interest and death without prior graft failure as a competing event. Write definitions that distinguish these outcomes from loss to follow-up.

Operational event rule. For this example, define graft failure as the first date on which the transplant is documented as permanently nonfunctional under a prespecified clinical criterion. This is a hypothetical operational choice; the actual criterion would need to be stated in the study protocol. A temporary decline that does not meet the permanent-failure criterion does not count as the event.

Competing event rule. Death before a qualifying graft failure is recorded as a competing event. It is not coded as censoring because death is observed and prevents a later graft failure from occurring in this first-event process.

Censoring rule. A recipient with no observed graft failure or death is censored on the earliest applicable date of the common administrative study end or the last date on which the recipient’s event status is known. The methods must state which date sources establish continued observation and how conflicting records are reconciled.

Suppose one hypothetical recipient’s graft failure is documented on day 240 after the origin date, with no earlier death. Then \(Y_i=240\) days and \(J_i\) is the graft-failure label. For another recipient who dies on day 180 without prior graft failure, \(Y_i=180\) days and \(J_i\) is the death-without-graft-failure label. If a third recipient is last known event-free on day 150 and has no later event record before administrative end, the recorded follow-up ends at day 150 and \(J_i=0\), provided the study’s ascertainment rule supports that censoring date. These assignments follow from the observed histories, not from a judgment that the censored recipient remained event-free indefinitely.

Time Origin, Entry, and End of Follow-Up

“Follow-up began at enrollment” is not sufficiently precise when enrollment can occur long after diagnosis, treatment, or another clinically meaningful date. State the time origin and the rule that determines each participant’s starting point. Examples include randomization, diagnosis, surgery, or a fixed eligibility date. Also state the time scale and units, such as days since surgery. If participants become eligible after the origin and enter observation later, report both the origin and the entry rule; otherwise, readers may mistake delayed observation for absence of earlier events.

Define the end of follow-up as a rule, not just a date label. Common endpoints include the first qualifying event, death, withdrawal of permission for further follow-up, loss to follow-up, or a common administrative closing date. When multiple endpoints could apply, say which earliest date determines the observed time. Specify whether the event date itself is included and how dates with limited precision are handled. These details matter when event dates are recorded only by month or when several events share a calendar date.

Censoring should describe the reason observation stopped. Administrative censoring is generally set by a common study closing date; loss to follow-up occurs when continued event ascertainment becomes unavailable; withdrawal may stop data collection under the applicable rules. These mechanisms are not interchangeable descriptions. For inference, censoring assumptions also matter: commonly, the analysis requires censoring to be independent of future event experience, at least conditional on variables included in the analysis. A clear definition helps assess that assumption but does not prove it.

Worked Example: Calculating Follow-Up Under Different End Rules

In a hypothetical study of first relapse after treatment, the time origin is the date treatment starts. A participant starts on March 1, has no relapse through the last verified contact on July 10, and the study closes on August 31. Assume the participant cannot be contacted after July 10, and no later event information is obtained.

If the stated rule censors at the last date known to be event-free, follow-up ends on July 10, not August 31. Using elapsed calendar days and excluding the origin date, March contributes 30 days after March 1, April 30, May 31, June 30, and July 10 days: \(30+30+31+30+10=131\) days. The record is therefore \(Y_i=131\) days with \(J_i=0\). The event-free status is established only through the last verified contact.

If instead the participant had documented event-free contacts through August 31, then the administrative closing date would determine censoring: March 30, April 30, May 31, June 30, July 31, and August 31 give \(30+30+31+30+31+31=183\) elapsed days. That is \(Y_i=183\) days and \(J_i=0\). The difference is not an arithmetic convention; it follows from what the study can establish about event status after July 10.

This calculation assumes the dates and the stated contact rule are accurate. A methods section should make the same choices explicit, including the origin-date convention, rather than leaving readers to infer them from a reported median follow-up.

Ambiguous, Multiple, and Simultaneous Causes

Clinical records may use inconsistent terminology, list several diagnoses, or fail to identify a single underlying cause. The report should say whether causes were determined by a hierarchy of coded diagnoses, adjudication, or another prespecified rule. If a hierarchy is used, state its ordering and justify it clinically. If cases may remain unresolved, state the label assigned to them and how they enter the analysis. The rule should be applied consistently without access to information that would make classification depend on the desired result.

When two qualifying events have the same recorded date, do not imply an ordering that the data cannot support. Specify whether more precise timestamps were used, whether a prespecified priority rule was applied, or whether the record was classified as simultaneous/ambiguous. If the analysis requires one first event, the chosen resolution rule must be transparent and its potential effect considered. A tie rule should not be invented after inspecting which classification gives more favorable results.

Worked Example: Two Plausible Causes on the Same Day

Consider a hypothetical first-event study of hospitalization for either infection or acute organ toxicity. The case record for one participant documents both diagnoses on the same hospital-admission date, but no reliable timestamps and no adjudication of which condition occurred first. Assigning the event to infection merely because infection is listed first in the record would be an undocumented and potentially arbitrary rule.

A reproducible plan could specify blinded clinical adjudication using defined criteria, with “both/indeterminate” retained if adjudicators cannot distinguish the causes. Alternatively, if the scientific endpoint is any hospitalization meeting either criterion, the analysis could define one composite event rather than claim to distinguish which cause occurred first. The appropriate choice depends on the endpoint; neither resolves the ambiguity by pretending the record contains information it does not.

Suppose a prespecified adjudication labels 7 of 40 such hypothetical records as infection, 5 as toxicity, and 28 as indeterminate or simultaneous. The arithmetic is \(7+5+28=40\), so all 40 records have an assigned outcome under this rule. The methods should still explain how the indeterminate group is treated in the analysis. The mere fact that categories sum to 40 does not make a cause-specific interpretation of the 28 unresolved cases justified.

Justification: Why a Competing Event Is Not Censoring

The distinction follows directly from what each recorded outcome says about the future event process. A competing event is an observed outcome that rules out the target event as a later first event. Censoring says only that event observation stopped at a particular time; the target event may occur later, but it is no longer observed. Treating a known competing event as censoring discards a real outcome and changes the interpretation of the data.

$$ \begin{aligned} J_i=k,\quad k\in\{1,\ldots,K\} &\quad\Longrightarrow\quad \text{a qualifying event of type }k\text{ was observed at }Y_i,\\ J_i=0 &\quad\Longrightarrow\quad \text{observation ended at }Y_i\text{ before a qualifying event was observed.} \end{aligned} $$

The first line records an event and its type; the second records incomplete event-time observation. If death is a competing event for relapse, replacing its event label with \(J_i=0\) would falsely describe death as mere loss of observation. Conversely, assigning a competing-event label to a participant whose records simply stop would claim an outcome that was not observed. This is a classification distinction, not a claim that censoring is harmless: inference still depends on appropriate assumptions about how censoring relates to future outcomes.

Methods Wording and Diagnostic Checks

A concise methods paragraph can be assembled from explicit rules rather than generic labels. For example: “Time zero was the date of [origin]. The event of interest was [operational criteria], dated at [date rule] and identified from [source]. [Named event] before the event of interest was treated as a competing event. Participants without either event were censored at the earliest of [specified endpoints]. Cause assignment used [source/adjudication rule]; simultaneous or unclassifiable events were [rule]. Follow-up was measured in [units] from time zero.” Replace each bracketed phrase with a study-specific definition.

Before finalizing the methods, check that every observed record can be assigned by the stated rules and that the assignment does not rely on unstated judgment. Useful diagnostics include:

  • Look for events with no cause label, multiple cause labels, or a date that precedes the stated follow-up origin.
  • Check whether “unknown cause,” “no event,” and “lost to follow-up” have been mistakenly combined.
  • Review records with same-day events and verify that the stated tie rule matches the available date precision.
  • Confirm that the stated endpoint actually precludes the target event as a later first event; if not, a competing-event label may be inappropriate.
  • Compare the written censoring rule with the dates used to create the analysis records, including administrative closure and last-known-status dates.

The main alternatives should be distinguished by their scientific meaning. A first-event competing-risk definition assigns one earliest event type or censoring status. A composite endpoint instead counts any event meeting one or more stated criteria as the same outcome, sacrificing separate cause labels. A multi-state description can retain sequences or transitions when one event does not end the possibility of another. These are not interchangeable coding conveniences: choose the representation that matches the question, then report its event definitions and rules.

A common mistake is to write, “Non-target events were censored at their occurrence.” That is wrong when a non-target event is an observed event that precludes the target first event: it is a competing event, not censoring. The correction is to name the event and its classification explicitly. A second mistake is to treat a missing cause as if no event occurred. State separately that an event was observed but its cause was unresolved, and document the prespecified handling rule.

Key takeaway: A reproducible competing-risk methods section defines the event criteria, cause assignment, time origin, follow-up end, censoring reasons, and rules for ambiguous or overlapping classifications. Competing events are observed outcomes; censoring is incomplete observation.

Check Your Understanding

Answer each question, then compare your reasoning with the solutions.

  1. A participant dies before a documented nonfatal relapse. Is death censoring or a competing event if the endpoint is first relapse? Explain.
  2. A participant has no recorded event and is last confirmed event-free on day 90. What additional detail is needed to report the censoring time reproducibly?
  3. A record documents two possible event causes on the same date, with no timestamps. Give two defensible ways to handle the ambiguity.
  4. Why should a case with an observed event but unknown cause not automatically be coded as “no event”?

Solutions. (1) Death is a competing event because it is observed and prevents a later relapse as the first event. (2) State the time origin, time units, the rule for last-known event-free status, and how day 90 was determined; also specify any competing administrative end rule. (3) Use a prespecified adjudication process with an unresolved category when necessary, or define a composite endpoint if that matches the scientific question; do not invent an ordering unsupported by the data. (4) The event occurrence is known even though its type is not. Coding it as “no event” would confuse missing cause information with absence of an observed event.

Clinical Biostats